FDA Inspection 1111704 — Sato Pharmaceutical Co., Ltd.

Sato Pharmaceutical Co., Ltd. — FEI 3004055563

The FDA completed an inspection of Sato Pharmaceutical Co., Ltd. on November 7, 2019 in Hachioji. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Food/Cosmetics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
November 7, 2019
Fiscal Year
2020
Product Type
Food/Cosmetics
Project Area
Food Composition, Standards, Labeling and Econ
Location
Hachioji (Japan)